Cargando…
SUMOylation as a Therapeutic Target for Myocardial Infarction
Myocardial infarction is a prevalent and life-threatening cardiovascular disease. The main goal of existing interventional therapies is to restore coronary reperfusion while few are designed to ameliorate the pathology of heart diseases via targeting the post-translational modifications of those cri...
Autores principales: | Zhao, Wei, Zhang, Xiuying, Rong, Jianhui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8355363/ https://www.ncbi.nlm.nih.gov/pubmed/34395563 http://dx.doi.org/10.3389/fcvm.2021.701583 |
Ejemplares similares
-
SUMOylation of Nuclear γ-Actin by SUMO2 supports DNA Damage Repair against Myocardial Ischemia-Reperfusion Injury
por: Zhao, Wei, et al.
Publicado: (2022) -
Upregulation of Small Ubiquitin-Like Modifier 2 and Protein SUMOylation as a Cardioprotective Mechanism Against Myocardial Ischemia-Reperfusion Injury
por: Zhao, Wei, et al.
Publicado: (2021) -
Mild Therapeutic Hypothermia Alters Hemostasis in ST Elevation Myocardial Infarction Patients
por: Scherz, Thomas, et al.
Publicado: (2021) -
Use of the Thrombolysis in Myocardial Infarction Risk Index for Elderly Patients With ST-Segment Elevation Myocardial Infarction
por: Fu, Bingqi, et al.
Publicado: (2021) -
Explore the Protective Role of Obesity in the Progression of Myocardial Infarction
por: Zhao, Siyuan, et al.
Publicado: (2021)